Evidence map›Paper›PMID 42307080›Full record

ArticleCNS neuroscience & therapeutics2026

Functional Brain Network Predictors of Abstinence Treatment Outcomes in Methamphetamine Use Disorder.

Yanyao Du, Shiqi Di, Na Luo, Wenhan Yang, Weiyang Shi, Zhengyi Yang, Ming Song, Huiting Zhang, Jun Zhang, Tianzi Jiang and 1 more

Abstract read
In one paragraph

Article in CNS neuroscience & therapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yanyao DuDepartment of Radiology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Shiqi DiBrainnetome Center, Institute of Automation, Chinese Academy of Sciences, Beijing, China.ORCID 0009-0001-3194-5950
Na LuoBrainnetome Center, Institute of Automation, Chinese Academy of Sciences, Beijing, China.
Wenhan YangDepartment of Radiology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Weiyang ShiBrainnetome Center, Institute of Automation, Chinese Academy of Sciences, Beijing, China.
Zhengyi YangBrainnetome Center, Institute of Automation, Chinese Academy of Sciences, Beijing, China.
Ming SongBrainnetome Center, Institute of Automation, Chinese Academy of Sciences, Beijing, China.
Huiting ZhangMR Research Collaboration, Siemens Healthineers Ltd., Wuhan, China.
Jun ZhangHunan Judicial Police Academy, Changsha, Hunan, China.
Tianzi JiangBrainnetome Center, Institute of Automation, Chinese Academy of Sciences, Beijing, China.
Jun LiuDepartment of Radiology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.ORCID 0000-0002-7851-6782

Funding

Graduate Innovation Project of Central South University 2023XQLH144Hunan Provincial Graduate Student Research Innovation Program CX20240306Innovative Province special construction foundation of Hunan Province 2019SK2131Innovative Province special construction foundation of Hunan Province 2020SK4001National Natural Science Foundation of China 61971451National Natural Science Foundation of China 62327805National Natural Science Foundation of China 82151307National Natural Science Foundation of China U22A20303Scientific Project of Zhejiang Lab 2022KI0AC02Scientific Project of Zhejiang Lab 2022ND0AN01STI2030-Major Projects 2021ZD0200201
6 · The paper itself

Abstract

backgroundMethamphetamine (MA) use poses a serious threat to community safety and public health. Despite the existence of some treatment modalities, relapse rates remain high and the effectiveness of these treatments varies among individuals. Identifying behavioral, neuroimaging, and gene expression biomarkers associated with treatment efficacy can enhance our multiscale understanding of the neurobiological mechanisms underlying individualized responses to abstinence-based treatments. This approach has the potential to advance the development of personalized or innovative therapeutic strategies.

methodsOur study included 82 MA users and 68 healthy controls (HCs). Demographic information, craving scale scores, MA use assessment, and MRI scans were collected from the MA group prior to treatment. All MA users underwent abstinence-based treatment, during which they refrained from using MA and received only basic medical care and education on abstinent rehabilitation. Following long-term abstinence-based treatment, craving scale scores were reassessed. A reduction in craving scale scores greater than 30% was defined as the responders. Similarly, demographic information and MRI scans were collected from the 68 HCs. We calculated whole-brain functional connectivity based on fMRI data and applied principal component regression (PCR) with leave-one-out cross-validation to identify response network patterns predictive of abstinence response scores. Furthermore, we evaluated the stability of the predictive models from multiple perspectives. Network strength of the identified response network was then compared to that of HCs to assess its clinical relevance. We also assessed the efficacy of network strength in making binary predictions. Finally, we combined the discovered brain patterns with the Allen Human Brain Atlas data to explore the genetic basis associated with the identified response network.

resultsAmong the 82 MA users, 39 were responders and 43 were non-responders. The 68 HCs had a mean age of 40.1 years, with 46 males. PCR identified a stable MA response network pattern, characterized by network connections positively associated with attention regulation and executive control abilities (within visual, between frontoparietal and default mode, and between visual and dorsal attention), as well as negative network connections associated with emotion regulation and behavioral automatization (within somatomotor, between somatomotor and default mode, and between default mode and ventral attention). HC exhibited moderate levels of network strength between responders and non-responders. The identified network pattern demonstrated efficacy in individual-level binary predictions. This neuroimaging pattern was further associated with synaptic signaling and inhibitory neurons.

conclusionsTogether, our results not only provide new neuroimaging markers for predicting personalized treatment response, but also reveal the underlying neurobiological mechanisms associated with abstinence response, providing potential regulatory targets for addiction treatment.

Indexed as

Amphetamine-Related DisordersBrainMethamphetamineNerve NetAdultCravingFemaleHumansMagnetic Resonance ImagingMaleTreatment OutcomeMethamphetaminebrain imagingcravingfunctional connectivity networkslong‐term methamphetamine abstinencemachine learningpredictive markers

Identifiers

PMID42307080
PMCPMC13273840

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.